Effects of cyclooxygenase-2 inhibitor on gastric acid secretion in Helicobacter pylori-infected C57BL/6 mice

Scandinavian Journal of Gastroenterology

Volumn 36, Issue 6, 2001, Pages 577-583

  Xiao, F ^a   Furuta, T ^a   Takashima, M ^a   Shirai, N ^a   Hanai, H ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acid secretion; Cyclooxygenase 2; Etodolac; Helicobacter pylori; Prostaglandin E2

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ETODOLAC; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG EFFECT; GASTRITIS; HELICOBACTER PYLORI; IMMUNOHISTOCHEMISTRY; INOCULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; SCORING SYSTEM; STAINING; STOMACH MUCOSA; STOMACH SECRETION;

EID: 0035023233     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655201750162971     Document Type: Article

References (42)

1. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation
2. Helicobacter pylori and peptic ulcers: The present position
3. Ulcerogenesis: Integrating the roles of Helicobacter pylori and acid secretion in duodenal ulcer
4. Campylobacter pylori and duodenal ulcers: The gastrin link
5. Role of Helicobacter pylori infection in gastro-duodenal secretion and in pathogenesis of peptic ulcer and gastritis
6. Helicobacter pylori infection and chronic gastric acid hyposecretion
7. Effect of Helicobacter pylori infection on gastric juice pH
8. Prostaglandin endoperoxide synthase: Why two isoforms?
9. Cytoprotection by prostaglandins
10. Prostanoids as regulators of gastrointestinal function
11. Prostaglandin E2 in gastric mucosa of children with Helicobacter priori gastritis: Relation to thickness of mucus gel layer
12. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro
13. A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain
14. Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57BL/6 mice and p53 hemizygous transgenic mice
15. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection
16. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa
17. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1
18. Tissue selective inhibition of prostaglandin biosynthesis by etodolac
19. Classification and grading of gastritis. The updated Sydney System
20. Helicobacter pylori infection: Physiopathologic implication of N alpha-methyl histamine
21. Effect of a Campylobacter pylori protein on acid secretion by parietal cells
22. Interaction of Helicobacter pylori and its fatty acids with parietal cells and gastric H+/K(+)-ATPase
23. Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat
24. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis
25. Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture
26. Proinflammatory cytokines interact synergistically with epidermal growth factor to stimulate PGE2 production in amnion-derived cells
27. Central and peripheral effects of prostaglandin E2 and enprostil on gastric acid secretion in the rat
28. Gastric bicarbonate secretion in humans. Effect of pentagastrin, bethanechol, and 11, 16, 16-trimethyl prostaglandin E2
29. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying
30. Central action of recombinant interleukin-1 to inhibit acid secretion in rats
31. Inhibition of acid formation in rabbit parietal cells by prostaglandins is mediated by the prostaglandin E2 receptor
32. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions
33. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis
34. Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans
35. Antral atrophy, Helicobacter pylori colonization, and gastric pH
36. Helicobacter pylori in dyspeptic patients: Quantitative association with severity of gastritis, intragastric pH, and serum gastrin concentration
37. Gastric precancerous process in a high risk population: Cross-sectional studies
38. Helicobacter pylori infection induces gastric cancer in mongolian gerbils
39. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils
40. Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H. pylori
41. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
42. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer